• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪血凝块对溶解的抗性与组织纤溶酶原激活剂对猪纤溶酶原的激活不足有关。

Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.

作者信息

Flight Simone M, Masci Paul P, Lavin Martin F, Gaffney Patrick J

机构信息

School of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.

出版信息

Blood Coagul Fibrinolysis. 2006 Jul;17(5):417-20. doi: 10.1097/01.mbc.0000233374.79593.57.

DOI:10.1097/01.mbc.0000233374.79593.57
PMID:16788320
Abstract

In-vitro experimentation was performed on porcine and human blood to determine their comparative responsiveness to a novel fibrinolytic inhibitor and thereby assess whether the pig is a suitable animal model for subsequent in-vivo testing of this inhibitor. Thromboelastography showed the clots formed from porcine whole blood to be highly resistant to tissue plasminogen activator (t-PA)-catalyzed lysis, and this communication offers the resistance of porcine plasminogen to activation by t-PA as an explanation. Porcine blood containing 100 and 1500 IU/ml added t-PA lysed very slowly, having LY30 values of 1.9 +/- 1.4 and 2.9 +/- 1.9%, respectively. In contrast, the LY30 values for the human clots containing 100 and 1500 IU/ml t-PA were 77.1 +/- 6.3 and 93.3 +/- 1.3%, respectively. Moreover, purified porcine plasminogen was activated very slowly by added t-PA in the presence of both human and porcine fibrin. Activation of plasminogen by the endogenous activators, as measured by the euglobulin clot lysis time, was greatly prolonged for the pig (22 +/- 3 h) compared with the human (3.5 +/- 1.5 h). These results suggest caution in using the pig as an experimental model when studying the effects of various agents on fibrinolysis.

摘要

在猪和人血液上进行了体外实验,以确定它们对一种新型纤溶抑制剂的相对反应性,从而评估猪是否是该抑制剂后续体内测试的合适动物模型。血栓弹力图显示,猪全血形成的凝块对组织纤溶酶原激活剂(t-PA)催化的溶解具有高度抗性,本报告提出猪纤溶酶原对t-PA激活的抗性作为解释。添加100和1500 IU/ml t-PA的猪血液溶解非常缓慢,LY30值分别为1.9±1.4%和2.9±1.9%。相比之下,含有100和1500 IU/ml t-PA的人凝块的LY30值分别为77.1±6.3%和93.3±1.3%。此外,在人和猪纤维蛋白存在的情况下,添加的t-PA对纯化的猪纤溶酶原的激活非常缓慢。通过优球蛋白凝块溶解时间测量,猪的内源性激活剂对纤溶酶原的激活与人类(3.5±1.5小时)相比大大延长(22±3小时)。这些结果表明,在研究各种药物对纤溶的影响时,使用猪作为实验模型时应谨慎。

相似文献

1
Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.猪血凝块对溶解的抗性与组织纤溶酶原激活剂对猪纤溶酶原的激活不足有关。
Blood Coagul Fibrinolysis. 2006 Jul;17(5):417-20. doi: 10.1097/01.mbc.0000233374.79593.57.
2
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.凝血酶激活的纤溶抑制物(TAFI)不会抑制药理浓度的组织型纤溶酶原激活剂(t-PA)在体外的溶栓作用。
Thromb Haemost. 2001 Apr;85(4):661-6.
3
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.
4
Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.回缩对使用纤维蛋白特异性和非纤维蛋白特异性纤溶酶原激活剂溶解人血凝块的影响。
Thromb Haemost. 1989 Dec 29;62(4):1083-7.
5
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).大剂量组织型纤溶酶原激活剂及血浆半衰期延长的杂交纤溶酶原激活剂(K2tu-PA:CGP 42935)的溶栓和出血作用
Thromb Haemost. 1993 Aug 2;70(2):294-300.
6
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitro.抗抑制剂组织型纤溶酶原激活剂:一种体外改良的溶栓剂。
Thromb Haemost. 1994 Jan;71(1):124-8.
7
Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).添加不同浓度重组组织型纤溶酶原激活剂(Rt-PA)后新生儿和成人全血凝块的溶解情况。
Semin Thromb Hemost. 1998;24(6):599-604. doi: 10.1055/s-2007-996060.
8
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.纤溶酶原激活剂的纤维蛋白特异性影响纤维蛋白溶解效率及对超声的反应性:九种纤溶酶原激活剂的体外比较
Thromb Haemost. 1999 Apr;81(4):605-12.
9
Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.维甲酸通过增强组织型纤溶酶原激活剂(t-PA)的活性来提高体内纤溶活性,并抑制静脉血栓形成。
Thromb Haemost. 1993 Apr 1;69(4):381-6.
10
Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.纤溶酶作为直接作用溶栓剂的跨物种药理学评价:用于大型动物模型开发的体外评价
J Vasc Interv Radiol. 2005 Mar;16(3):369-77. doi: 10.1097/01.RVI.0000148828.40438.D3.

引用本文的文献

1
Recanalization and reperfusion in clinically-relevant porcine model of stroke.在具有临床相关性的猪中风模型中的再通和再灌注
Front Neurosci. 2025 Jun 5;19:1572925. doi: 10.3389/fnins.2025.1572925. eCollection 2025.
2
Dissolving porcine and human microthrombi by short exposure to microdoses of alteplase in an in vitro model of microvascular obstruction.在微血管阻塞的体外模型中,通过短期暴露于微量阿替普酶来溶解猪和人的微血栓。
Sci Rep. 2025 May 24;15(1):18114. doi: 10.1038/s41598-025-03060-1.
3
Assessment of effectiveness and safety of thrombolytic therapy to pulmonary emboli by endobronchial ultrasound-guided transbronchial needle injection.
经支气管超声引导经支气管针注射对肺栓塞溶栓治疗的有效性和安全性评估。
JTCVS Tech. 2023 Sep 20;22:292-304. doi: 10.1016/j.xjtc.2023.09.005. eCollection 2023 Dec.
4
Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.氙气载入脂质体联合 rtPA 溶栓对栓塞性缺血性脑卒中的增强脑保护作用。
Biomolecules. 2023 Aug 16;13(8):1256. doi: 10.3390/biom13081256.
5
Reference Range of Kaolin-Activated Thromboelastography (TEG) Values in Healthy Pet Rabbits ().健康宠物兔高岭土激活血栓弹力图(TEG)值的参考范围()。
Animals (Basel). 2023 Jul 23;13(14):2389. doi: 10.3390/ani13142389.
6
Effect of Thrombin and Incubation Time on Porcine Whole Blood Clot Elasticity and Recombinant Tissue Plasminogen Activator Susceptibility.凝血酶和孵育时间对猪全血凝块弹性和重组组织型纤溶酶原激活剂敏感性的影响。
Ultrasound Med Biol. 2022 Aug;48(8):1567-1578. doi: 10.1016/j.ultrasmedbio.2022.04.003. Epub 2022 May 26.
7
Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi.评估静脉血栓的组织学特征、影像学标志物和 rt-PA 敏感性。
Sci Rep. 2021 Nov 23;11(1):22805. doi: 10.1038/s41598-021-02030-7.
8
In Vivo Porcine Aged Deep Vein Thrombosis Model for Testing Ultrasound-based Thrombolysis Techniques.基于超声的溶栓技术的体内猪陈旧性深静脉血栓模型。
Ultrasound Med Biol. 2021 Dec;47(12):3447-3457. doi: 10.1016/j.ultrasmedbio.2021.08.017. Epub 2021 Sep 28.
9
Chronic Thromboembolic Pulmonary Hypertension: the Bench.慢性血栓栓塞性肺动脉高压:基础研究。
Curr Cardiol Rep. 2021 Aug 19;23(10):141. doi: 10.1007/s11886-021-01572-6.
10
Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery.用于治疗和药物递送的超声响应性空化核
Ultrasound Med Biol. 2020 Jun;46(6):1296-1325. doi: 10.1016/j.ultrasmedbio.2020.01.002. Epub 2020 Mar 10.